08-05 CapAI Conditionally Raises Funds via Share Placing, Subscription MT
07-23 Somero ups buyback; Talisman opportunistic discovery AN
07-23 CapAI Signs License, Option Deal for R42 Group's AI Health Data Platform MT
07-23 WINNERS & LOSERS: capAI gains exclusive licence for Ageotype platform AN
07-23 Capai plc Enters Licence and Option Agreement with R42 Group Llc for Ageotype Longevity Platform CI
07-09 CapAI extends licenses; B Hodl launches buyback AN
07-09 CapAI Extends AI Platform License, Option Agreements With R42 MT
06-30 CapAI Plc Reports Earnings Results for the Half Year Ended March 31, 2026 CI
06-09 CapAI plc Announces Public Availability of Movie42 and Gamers42 Beta Applications and Expanded Author42 Capabilities CI
04-21 CapAI hails outlook; Intercede wins new orders AN
04-21 Capai plc Announces Appointment of John Frame Allardyce as Director CI
02-10 Hemogenyx raises funds for phase I trials AN
02-10 CapAI Raises Funds Via Share Placing, Subscription for AI Initiatives MT
01-30 CapAI Plc Reports Earnings Results for the Full Year Ended September 30, 2025 CI
12-17 CapAI plc Announces Board and Committee Changes CI
11-18 Capai plc Announces Soft Launch of Author42 CI
11-05 CapAI to Start Trading on OTCQB Venture Market in US MT
25-10-15 CapAI Receives Completion Notice for Creator42 MT
25-10-14 CapAI Shares Shift to LSE's SETS Platform MT
25-10-14 CapAI transitions trading to SETS platform effective today RE
25-10-07 CapAI Incorporates US Subsidiary in Delaware, Renames UK Units MT
25-10-07 Capai announces incorporation of Capmedical Inc RE
25-10-07 CapAI plc Announces Incorporation of capMedical Inc CI
25-09-19 CapAI : Notice of General Meeting PU
25-09-05 CapAI hires Jayne Lytel to drive capMedia's AI architecture AN
No results match your criteria